IBN (InvestorBrandNetwork) Announces Latest Episode of The Bell2Bell Podcast Featuring Hector Bremner, CEO of Avricore Health Inc.
October 05 2021 - 7:17AM
via InvestorWire -- IBN (InvestorBrandNetwork), a multifaceted
communications organization engaged in connecting public companies
to the investment community, is pleased to announce the release of
the latest episode of The Bell2Bell Podcast as part of its
sustained effort to provide specialized content distribution via
widespread syndication channels.
The Bell2Bell Podcast delivers informative updates and exclusive
interviews with executives operating in fast-moving industries.
Bell2Bell’s latest podcast features Hector Bremner, CEO of Avricore
Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF), a pharmacy service
innovator focused on acquiring and developing early-stage
technologies aimed at moving pharmacy forward.
Throughout the interview, Bremner discussed Avricore’s business
model and the company’s continuing efforts to lead the charge and
improve early detection and screening practices throughout the
health care industry.
“We’re a company focused on diagnostics. We place a system
within the pharmacy where a blood test or a molecular test can be
done. A simple sample is collected, and the whole test takes about
15 minutes,” Bremner said. “Our technology is a cloud-based
solution that networks these high-quality analyzers from companies
like Abbott and is able to then create a testing network in the
pharmacy… The patient gets to keep their information, of course…
but really, the objective here is to create a global network of
pharmacies reporting back real-time information on patient data
that can be used for study and research purposes, which is a very,
very high demand out there in the sector.”
“My background, funnily enough, was not in health care nor
public companies. I was actually in government,” he continued.
“Leading into Avricore Health, what got me excited was that we have
a disease care system in [Canada], and I’ve always really believed
that we need a true health care system that values early detection
and screening if we really want to make sure that we’re not only
saving lives but saving health care dollars in the future. We’re
really passionate about leading this charge… We’ve got a company
that is in great shape and fully funded. We’re growing, and we’ve
got a lot of blue sky ahead of us.”
Bremner then discussed some of the recent milestones for
Avricore Health.
“One milestone that I’m really proud of is that by the late
summer/early fall of 2020, we had begun discussions with Abbott
Diagnostics. Ultimately, we concluded multiple distribution
agreements with them, which was pretty groundbreaking in the sense
that they do not do distribution agreements for their technology
with third-party technology companies like us,” he noted.
“Normally, to distribute Abbott technologies at this level, you
have to be a fairly large distributor of health care technologies
to begin with. We were extremely fortunate to pioneer this
agreement and really break ground to see what was possible as a
value-added reseller to bring our technology in combination with
theirs. This has really been a jump-off point for us; it’s really
accelerated our growth.”
Join IBN’s Stuart Smith and Hector Bremner, CEO of Avricore
Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF), to learn more about the
company’s recent agreement with Shoppers Drug Mart and its goals
for the balance of 2021 and beyond.
To hear the episode and subscribe to future podcasts,
visit https://podcast.bell2bell.com.
The latest installment of The Bell2Bell Podcast continues to
reinforce IBN’s commitment to the expansion of its robust network
of brands, client partners, followers and the growing IBN Podcast
Series. For more than 15 years, IBN has leveraged this commitment
to provide unparalleled distribution and corporate messaging
solutions to 500+ public and private companies.
To learn more about IBN’s achievements and milestones via a
visual timeline, visit https://IBN.fm/TimeLine.
About Avricore Health Inc.
Avricore Health Inc. is a pharmacy service innovator focused on
acquiring and developing early-stage technologies aimed at moving
pharmacy forward. Through flagship offering HealthTab™ (a wholly
owned subsidiary), its mission is to make actionable health
information more accessible to everyone by creating the world’s
largest network of rapid testing devices in community pharmacies.
For more information, visit the company’s website at
www.AvricoreHealth.com.
About IBN
IBN (InvestorBrandNetwork) consists of financial brands
introduced to the investment public over the course of 15+ years.
With IBN, we have amassed a collective audience of millions of
social media followers. These distinctive investor brands aim to
fulfill the unique needs of a growing base of client-partners. IBN
will continue to expand our branded network of highly influential
properties, leveraging the knowledge and energy of specialized
teams of experts to serve our increasingly diversified list of
clients.
Through NetworkNewsWire (“NNW”) and its affiliate brands, IBN
provides: (1) access to a network of wire solutions via
InvestorWire to reach all target markets, industries and
demographics in the most effective manner possible; (2) article and
editorial syndication to 5,000+ news outlets; (3) enhanced press
release solutions to ensure maximum impact; (4) full-scale
distribution to a growing social media audience; (5) a full array
of corporate communications solutions; and (6) a total news
coverage solution.
For more information, please visit
https://www.InvestorBrandNetwork.com.
Please see full terms of use and disclaimers on the
InvestorBrandNetwork website applicable to all content provided by
IBN, wherever published or re-published:
http://IBN.fm/Disclaimer
Forward-Looking Statements
This release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended.
All forward-looking statements are inherently uncertain as they are
based on current expectations and assumptions concerning future
events or future performance of the company. Readers are cautioned
not to place undue reliance on these forward-looking statements,
which are only predictions and speak only as of the date hereof. In
evaluating such statements, prospective investors should review
carefully various risks and uncertainties identified in this
release and matters set in the company's SEC filings. These risks
and uncertainties could cause the company's actual results to
differ materially from those indicated in the forward-looking
statements.
Corporate Communications
IBN (InvestorBrandNetwork)Los Angeles,
Californiawww.InvestorBrandNetwork.com310.299.1717
OfficeEditor@InvestorBrandNetwork.com
Avricore Health (TSXV:AVCR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Avricore Health (TSXV:AVCR)
Historical Stock Chart
From Apr 2023 to Apr 2024